|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/353 | |
| A61K 31/357 | |||
| A61K 31/36 | |||
| A61P 25/06 |
| (11) | Number of the document | 2150249 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07757059.6 |
| Date of filing the European patent application | 2007-02-15 | |
| (97) | Date of publication of the European application | 2010-02-10 |
| (45) | Date of publication and mention of the grant of the patent | 2013-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/062241 |
| Date | 2007-02-15 |
| (87) | Number | WO 2007/095618 |
| Date | 2007-08-23 |
| (30) | Number | Date | Country code |
| 773764 P | 2006-02-15 | US | |
| 674021 | 2007-02-12 | US |
| (72) |
SMITH-SWINTOSKY, Virginia L., US
|
| (73) |
Janssen Pharmaceutica N.V.,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE |
| USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE |